Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

MIMEDX GROUP, INC. (MDXG)

$3.91 -0.51% NASDAQ: MDXG · 15-min delayed
  • MARIETTA, Georgia
  • Public · NASDAQ: MDXG
  • 808 employees
$625.6MMarket cap
$418.6MRevenue · FY2025
$48.6MNet income
808Employees
MDXGNASDAQ
2007IPO

About MIMEDX GROUP, INC.

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$418.6M
Net income
$48.6M
Total assets
$342.7M
Market cap
$625.6M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: MDXG
$3.91 -0.51%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.08 $7.96

52-week range

Market cap
$625.6M
Shares outstanding
160.0M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Aug 22, 2007

Mimedx Group, Inc. (MDXG) Stock Price

  • Profitable — net income of $48.6M in FY2025.
  • Trading 51% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review MIMEDX GROUP, INC..

Write a review
Newsroom

News about MIMEDX GROUP, INC.

News & sentiment via Polygon.io

FAQ

Mimedx Group, Inc.: frequently asked questions

Is Mimedx Group, Inc. an American company?

Mimedx Group, Inc. is a US-based company headquartered in Marietta, Georgia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Mimedx Group, Inc. headquartered?

Mimedx Group, Inc. is headquartered in Marietta, Georgia, United States.

Is Mimedx Group, Inc. publicly traded?

Yes — Mimedx Group, Inc. is a publicly traded company. Its stock trades under the ticker symbol MDXG on the NASDAQ.

What does Mimedx Group, Inc. do?

Mimedx Group, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →